Matches in Nanopublications for { ?s ?p "[Additional highly localized DNA amplifications suggested candidate oncogenes not previously identified as amplified in SCLC, including the antiapoptotic genes TNFRSF4 (1p36), DAD1 (14q11), BCL2L1 (20q11) and BCL2L2 (14q11).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP380145.RAtdXSMK3pESaaNCamu7SCT87lNW9iaLQ-xQBnd8q8lIQ130_assertion description "[Additional highly localized DNA amplifications suggested candidate oncogenes not previously identified as amplified in SCLC, including the antiapoptotic genes TNFRSF4 (1p36), DAD1 (14q11), BCL2L1 (20q11) and BCL2L2 (14q11).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380145.RAtdXSMK3pESaaNCamu7SCT87lNW9iaLQ-xQBnd8q8lIQ130_provenance.
- NP935627.RAo9saDXnB31OqyGIqtbjPCudi4NgX-ax0UgRM0Dz8sn4130_assertion description "[Additional highly localized DNA amplifications suggested candidate oncogenes not previously identified as amplified in SCLC, including the antiapoptotic genes TNFRSF4 (1p36), DAD1 (14q11), BCL2L1 (20q11) and BCL2L2 (14q11).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP935627.RAo9saDXnB31OqyGIqtbjPCudi4NgX-ax0UgRM0Dz8sn4130_provenance.
- NP819186.RAgY1uOOPDOJfT55I-eNg3L2ksj8JoyxPBvGdimXtjNUE130_assertion description "[Additional highly localized DNA amplifications suggested candidate oncogenes not previously identified as amplified in SCLC, including the antiapoptotic genes TNFRSF4 (1p36), DAD1 (14q11), BCL2L1 (20q11) and BCL2L2 (14q11).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP819186.RAgY1uOOPDOJfT55I-eNg3L2ksj8JoyxPBvGdimXtjNUE130_provenance.
- NP165193.RA00SoiuGIlVRrnbwTc_vBgIjleEqu3ZVETFFHQQdjAno130_assertion description "[Additional highly localized DNA amplifications suggested candidate oncogenes not previously identified as amplified in SCLC, including the antiapoptotic genes TNFRSF4 (1p36), DAD1 (14q11), BCL2L1 (20q11) and BCL2L2 (14q11).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165193.RA00SoiuGIlVRrnbwTc_vBgIjleEqu3ZVETFFHQQdjAno130_provenance.
- NP913585.RA0g2tDuNCk43g8xCk2rAeQMB4-yXszI2c8Jw8EhWcGSE130_assertion description "[Additional highly localized DNA amplifications suggested candidate oncogenes not previously identified as amplified in SCLC, including the antiapoptotic genes TNFRSF4 (1p36), DAD1 (14q11), BCL2L1 (20q11) and BCL2L2 (14q11).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913585.RA0g2tDuNCk43g8xCk2rAeQMB4-yXszI2c8Jw8EhWcGSE130_provenance.
- NP264705.RAc4xNZBah0M7EwSGhwqhOYuMJ1IvzNtVDeNc3GSN7q0w130_assertion description "[Additional highly localized DNA amplifications suggested candidate oncogenes not previously identified as amplified in SCLC, including the antiapoptotic genes TNFRSF4 (1p36), DAD1 (14q11), BCL2L1 (20q11) and BCL2L2 (14q11).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP264705.RAc4xNZBah0M7EwSGhwqhOYuMJ1IvzNtVDeNc3GSN7q0w130_provenance.
- assertion description "[Additional highly localized DNA amplifications suggested candidate oncogenes not previously identified as amplified in SCLC, including the antiapoptotic genes TNFRSF4 (1p36), DAD1 (14q11), BCL2L1 (20q11) and BCL2L2 (14q11).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Additional highly localized DNA amplifications suggested candidate oncogenes not previously identified as amplified in SCLC, including the antiapoptotic genes TNFRSF4 (1p36), DAD1 (14q11), BCL2L1 (20q11) and BCL2L2 (14q11).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Additional highly localized DNA amplifications suggested candidate oncogenes not previously identified as amplified in SCLC, including the antiapoptotic genes TNFRSF4 (1p36), DAD1 (14q11), BCL2L1 (20q11) and BCL2L2 (14q11).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP510257.RAUs6tJ2PnrvPiFjfHzflSLCGeqbUNmSHM1KaMIzrgi04130_assertion description "[Additional highly localized DNA amplifications suggested candidate oncogenes not previously identified as amplified in SCLC, including the antiapoptotic genes TNFRSF4 (1p36), DAD1 (14q11), BCL2L1 (20q11) and BCL2L2 (14q11).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP510257.RAUs6tJ2PnrvPiFjfHzflSLCGeqbUNmSHM1KaMIzrgi04130_provenance.
- NP1015680.RAjqv5qmEZBaYFzPnp15Ey51OCA6JDeMadYLcAh8jD7xg130_assertion description "[Additional highly localized DNA amplifications suggested candidate oncogenes not previously identified as amplified in SCLC, including the antiapoptotic genes TNFRSF4 (1p36), DAD1 (14q11), BCL2L1 (20q11) and BCL2L2 (14q11).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1015680.RAjqv5qmEZBaYFzPnp15Ey51OCA6JDeMadYLcAh8jD7xg130_provenance.